An Extension Trial of Inclisiran in Participants With Cardiovascular Disease and High Cholesterol
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Novartis Pharmaceuticals
Related studies linked through entity extraction aliases.
Study Assessing the Efficacy and Safety of Alpelisib Plus Fulvestrant or Letrozole, Based on Prior Endocrine Therapy, in Patients With PIK3CA Mutant, HR+, HER2- Advanced Breast Cancer Who Have Progressed on or After Prior Treatments
- Status
- COMPLETED
- Phase
- PHASE2
Study to Explore the Effect of Secukinumab, Compared to Placebo, on Fat Tissue and Skin in Plaque Psoriasis Patients
- Status
- COMPLETED
- Phase
- PHASE4
Pasireotide in Hyperinsulinemic Hypoglycemia
- Status
- WITHDRAWN
- Phase
- PHASE2
Study of Safety of QAW039 in Patients With Asthma Inadequately Controlled on Standard-of-care Asthma Treatment
- Status
- TERMINATED
- Phase
- PHASE3
A Companion Sample Collection Protocol to Support the Discovery of Breast Cancer Aberrations With Treatment of CDK4/6 Therapy/LEE011/Ribociclib
- Status
- TERMINATED
- Phase
- PHASE3
Pharmacokinetics of Fevipiprant (QAW039) in Patients With Hepatic Impairment Compared to Matched Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Study to Allow Patients Previously Participating in a Novartis Sponsored Trial to Continue Receiving Capmatinib Treatment as Single Agent or in Combination With Other Treatments or the Combination Treatment Alone
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Secukinumab Safety and Efficacy in Juvenile Psoriatic Arthritis (JPsA) and Enthesitis-related Arthritis (ERA)
- Status
- COMPLETED
- Phase
- PHASE3
A Phase II Dose-escalation Study Characterizing the PK of Eltrombopag in Pediatric Patients With Previously Untreated or Relapsed Severe Aplastic Anemia or Recurrent Aplastic Anemia
- Status
- COMPLETED
- Phase
- PHASE2
Study of the Efficacy of Early Intervention With Secukinumab 300 mg s.c. Compared to Narrow-band UVB in Patients With New-onset Moderate to Severe Plaque Psoriasis
- Status
- COMPLETED
- Phase
- PHASE4
Ribociclib and Doxorubicin in Treating Patients With Metastatic or Advanced Soft Tissue Sarcomas That Cannot Be Removed by Surgery
- Status
- COMPLETED
- Phase
- PHASE1
Safety, Pharmacokinetics and Efficacy of Bimagrumab in Overweight and Obese Patients With Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE2
Study of Efficacy and Safety of CJM112 in Patients With Moderate to Severe Inflammatory Acne
- Status
- COMPLETED
- Phase
- PHASE2
Eltrombopag Combined With Cyclosporine as First Line Therapy in Patients With Severe Acquired Aplastic Anemia
- Status
- COMPLETED
- Phase
- PHASE2
Open-label, Multicenter Study Assessing Preference for Deferasirox Film-coated Tablet Compared to Dispersible Tablet
- Status
- COMPLETED
- Phase
- PHASE2
Phase I Study of MIK665, a Mcl-1 Inhibitor, in Patients With Refractory or Relapsed Lymphoma or Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
RAD001 and Neurocognition in PTEN Hamartoma Tumor Syndrome
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Phase IV Study to Evaluate Safety, Tolerability and Effectiveness of Rivastigmine Patch 15cm2 in Patients With Severe Dementia of the Alzheimer's Type.
- Status
- COMPLETED
- Phase
- PHASE4
Study of Safety and Tolerability of PDR001 in Combination With Sorafenib and to Identify the Maximum Tolerated Dose and/or Phase 2 Dose for This Combination in Advanced Hepatocellular Patients
- Status
- COMPLETED
- Phase
- PHASE1